| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Alzheimer Disease | Phase 2 | ClinicalTrials |
| Aggression; Alzheimer Disease; Psychomotor Agitation | Phase 2 | ClinicalTrials |
| Dementia; Down Syndrome; Syndrome | Phase 2 | ClinicalTrials |
| Disease | Phase 2 | ClinicalTrials |
CONTENTS